Medisafe®, the leading personalized medication management platform with over three and a half million patient and caregiver registered users, announced today that it has raised a $14.5M Series B funding round led by Octopus Ventures, and joined by M Ventures, to support the company's rapid growth and global expansion. Other investors participating from previous rounds include Pitango Venture Capital, 7wire ventures, lool Ventures, TriVentures and Qualcomm Ventures.
Medisafe is focused on helping hundreds of millions of people worldwide to take their medications as prescribed, solving the problem known as medication non-adherence. Non-adherence is one of the most dire issues and complex behavioral challenges in healthcare that, in the U.S. and Europe alone, is estimated to cause a death every four minutes, and places a burden to health systems estimated at a combined $500 billion annually. Moreover, pharmaceutical companies globally lose an estimated $637 billion each year due to medication non-adherence, bringing total costs to well over $1 trillion... READ MORE